ABL800 Flex

Comparison of ionised calcium measured using a portable analyser to a reference method in healthy dogs.

Pediatric ionized calcium reference intervals from archived radiometer data.

Estimating blood nitrate concentration from interference on radiometer ABL800 chloride electrode.

A case of pseudohyperchloraemia caused by sodium nitrate ingestion.

The effects of copper, zinc and bicarbonate in blood, kidney and liver in rats under intermittent hypobaric hypoxia.

apsule Size Alters the Timing of Metabolic Alkalosis Following Sodium Bicarbonate Supplementation.

Effectiveness of fetal scalp stimulation test in assessing fetal wellbeing during labor, a retrospective cohort study.

Intravenous iron in clinical concentrations does not impair haemoglobin measurement.

Failing blood gas measurement due to methemoglobin forming hemoglobin variants: a case report and review of the literature.

The expansion of POCT at MIM-NRI between 2017 and 2024 highlights the vital role of rapid bedside diagnostics in modern clinical practice. By integrating a high volume of tests with robust quality management systems like AQURE, the hospital has successfully balanced speed with analytical precision. Ultimately, these tools are indispensable for accelerating life-saving treatments and optimizing hospital efficiency in critical care settings.

Comparison of blood gas results obtained on Abbott i-Stat® and on Radiometer ABL 800 Flex® analyzers Impact for the clinical decision.

"A testing sequence combining a risk factor questionnaire, POC test and confirmatory laboratory testing appears to be cost-effective compared to current practice. The cost-effectiveness of POC testing appears to be driven by reduced delays within the CECT pathway. The contribution of intravenous contrast media to acute kidney injury, and the benefits and harms of intravenous hydration remain uncertain."

"Umbilical cord blood lactate level measured by StatStrip Lactate was lower than estimated by the ABL800 FLEX gas analyzer. This shows the necessity to develop decision-making reference points separately for each device. Umbilical cord blood pH, BE, pO2 and pCO2, ctHb and ctBl levels did not affect the accuracy of measurements by electrochemical portable devices."

"A three-step testing sequence combining a risk factor questionnaire with a point-of-care test [i-STAT, ABL800 FLEX and StatSensor] and confirmatory laboratory testing appears to be a cost-effective use of NHS resources compared with current practice. The risk of contrast causing acute kidney injury to patients with an estimated glomerular filtration rate of < 30 ml/minute/1.73 m² is uncertain. Cost-effectiveness of point-of-care testing [i-STAT, ABL800 FLEX and StatSensor] appears largely driven by the potential of point-of-care tests to minimise delays within the current computed tomography pathway."

Validation of a point-of-care capillary lactate measuring device (Lactate Pro 2).

"The screening of patients at risk of CI-AKI may be feasible with PoC technology. However, in this study, it was identified that the analyser [Nova StatSensor, Abbott i-STAT and Radiometer ABL800 FLEX] concordance with the laboratory reference varies. It is proposed that further research exploring PoC implementation in imaging department pathways is needed."

Comparison of 3 different multianalyte point-of-care devices during clinical routine on a medical intensive care unit.

"There was a good correlation between the Nova Stat Profile Prime Plus® and the Radiometer ABL800 FLEX®/Abbott i-STAT Chem8+® POCT analyzers. The Stat Profile Prime Plus® exhibited good precision both within-run and day-to-day."

"A fetal blood lactate concentration greater than or equal to 7.0 mmol/L measured by [StatStrip® Lactate 2] corresponds to the established intervention cutoff lactate value greater than or equal to 5.2 mmol/L measured by [StatStrip® Lactate]. Precision was acceptable but may be improved by using the mean of two measurements, particularly when the first result falls between 6.0 and 8.0 mmol/L. We also recommend ensuring the correct sampling techniques to minimize preanalytical variation."

This independent validation study confirms that the cobas® pulse point-of-care system provides clinically satisfactory performance as a successor to the Accu-Chek® Inform II. The device demonstrated strong correlation and agreement with both the cobas® 8000 and the ABL800 Flex, with the latter showing particularly high precision (bias of -0.01 mmol/L). Furthermore, the accuracy remained within allowable limits across both low and high glycemic ranges. Consequently, the cobas® pulse proves to be a reliable and accurate tool for blood glucose monitoring in clinical settings.

Comparison of venous lactate values on blood gas analyser versus laboratory autoanalyser: A preliminary study.

Hemoglobin determination with point-of-care testing, performance evaluation compared to central laboratory analyzers in transfusion decision, an in vitro and retrospective study.

Resolving Pseudohyponatremia: Validation of Plasma Sodium on Radiometer ABL800 Blood Gas Analyzers for Immediate Reflex Testing.

Hyperkalemia measurement between Blood Gas Analyser and Main Laboratory Biochemistry Analyser.

"Many interventions like substitution of fluids, coagulating factors or RBC units rely on the accuracy of laboratory measurement devices. Although BGA Hb testing showed a consistently stable difference to CL, our data confirm that BGA devices are associated with different bias. Therefore, we suggest that hospitals assess their individual bias before implementing BGA as valid and stable supplement to CL. However, based on the finding that bias decreased with smaller Hb values, which in turn are used for transfusion decision, we expect no unnecessary or delayed RBC transfusion, and no major impact on the LIBERAL trial performance."

Hemoglobin Measurement by Point-of-Care Blood Gas Analysis Versus Central Laboratory in Hemodialysis Patients.

"A three-step testing sequence combining a risk factor questionnaire with a point-of-care test [i-STAT, ABL800 FLEX and StatSensor] and confirmatory laboratory testing appears to be a cost-effective use of NHS resources compared with current practice. The risk of contrast causing acute kidney injury to patients with an estimated glomerular filtration rate of < 30 ml/minute/1.73 m² is uncertain. Cost-effectiveness of point-of-care testing [i-STAT, ABL800 FLEX and StatSensor] appears largely driven by the potential of point-of-care tests to minimise delays within the current computed tomography pathway."